- According to estimates from 7 analysts, Kestra Medical Technologies, Ltd. stock's average price target has risen from $27.71 to $28.43, with forecasts ranging from $19 to $32 per share
- Based on the Jul. 14 closing price, the updated target implies approximately 18% potential upside
- Consensus rating remains at “Buy” across 7 covering analysts, with 6 Buys, 1 Holds and 0 Sells
Explore more price target data and ratings for Kestra Medical Technologies, Ltd. on the , and track all previous and future analyst recommendations for Kestra Medical Technologies, Ltd. in the dedicated .
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.